Multifunctional Excipients
ePT--the Electronic Newsletter of Pharmaceutical Technology
Palatinit's "galenIQ" is line of multifunctional excipients that offer the combined advantages of other bulk excipients.
Palatinit's (Morris Plains, NJ, www.palatinit.com) "galenIQ" is line of multifunctional excipients that offer the combined advantages of other bulk excipients.
galenIQ is a disaccharide alcohol based on hydrogenated isomaltulose (HI). galenIQ is exclusively derived from sucrose in a two-stage production process and is a white, odorless, water-soluble, crystalline substance that complies with the isomalt monographs of the current Ph Eur, BP, and USP29-NF24.
According to Palatinit, the combination of low hygroscopicity and anti-caking property can ease production processes such as mixing, agglomeration, or tableting, and can reduce the need for costly protective packaging.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
